Stay updated on Clinical Trial: Olaparib + Abiraterone in Prostate Cancer
Sign up to get notified when there's something new on the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page.

Latest updates to the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page
- Check8 days agoChange DetectedA new platform revision label, v3.6.4, was added to the history, replacing the previous v3.6.3. This reflects a software release for the page and does not modify study records or displayed content.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.6.3 was added to the page history and Revision: v3.6.2 was removed, reflecting a small system update to the site’s version labeling rather than changes to the study record.SummaryDifference0.1%

- Check36 days agoChange DetectedThe study record history displays a new revision entry (v3.6.2) added and an older revision (v3.6.0) removed, updating the page's revision metadata in the history view.SummaryDifference0.1%

- Check43 days agoChange DetectedA new entry dated 2026-06-18 and an additional 2026-05-27 entry (version 25) were added to the study history. The 2026-03-11 entry was removed.SummaryDifference0.3%

- Check50 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is not currently enrolling. The record revision was updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.3%

- Check57 days agoChange DetectedThe revision tag in the page footer updated from v3.5.4 to v3.5.5, signaling a platform update; visible study history and details remain unchanged.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Olaparib + Abiraterone in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page.